Published in Adv Virol on June 13, 2013
Multivalent and Multipathogen Viral Vector Vaccines. Clin Vaccine Immunol (2017) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
The complete DNA sequence of varicella-zoster virus. J Gen Virol (1986) 16.00
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med (2009) 7.33
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis (2012) 3.94
Selective cleavage of human DNA: RecA-assisted restriction endonuclease (RARE) cleavage. Science (1991) 3.87
Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc Natl Acad Sci U S A (1993) 2.55
Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein. Proc Natl Acad Sci U S A (2004) 2.51
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol (1998) 2.48
Varicella in children with cancer: Seventy-seven cases. Pediatrics (1975) 2.29
Viral vectors as vaccine platforms: deployment in sight. Curr Opin Immunol (2011) 1.80
A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. J Virol (2007) 1.76
The DNA sequence of the simian varicella virus genome. Virology (2001) 1.67
Zoster vaccine: current status and future prospects. Clin Infect Dis (2010) 1.58
Review: The neurobiology of varicella zoster virus infection. Neuropathol Appl Neurobiol (2011) 1.45
Simian varicella: a model for human varicella-zoster virus infections. Rev Med Virol (2004) 1.41
Perspectives on mucosal vaccines: is mucosal tolerance a barrier? J Immunol (2007) 1.28
Antigenic relationships among several simian varicella-like viruses and varicella-zoster virus. Infect Immun (1977) 1.27
Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine (2004) 1.27
Neuronal localization of simian varicella virus DNA in ganglia of naturally infected African green monkeys. Virus Genes (2004) 1.26
Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. Trans Am Clin Climatol Assoc (2012) 1.18
Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis (2008) 1.18
Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. J Infect Dis (2006) 1.17
Varicella-zoster virus as a live vector for the expression of foreign genes. Proc Natl Acad Sci U S A (1987) 1.15
Effectiveness of varicella vaccine in children infected with HIV. J Infect Dis (2010) 1.14
Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006. Pediatrics (2007) 1.14
The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka). J Virol (1990) 1.13
Simian varicella virus DNA in dorsal root ganglia. Proc Natl Acad Sci U S A (1991) 1.11
Pathogenesis of simian varicella virus. J Med Virol (2003) 1.10
The simian varicella virus and varicella zoster virus genomes are similar in size and structure. Virology (1992) 1.08
Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen. J Gen Virol (1991) 1.06
Simian varicella in old world monkeys. Comp Med (2008) 1.02
Infectious simian varicella virus expressing the green fluorescent protein. J Neurovirol (1998) 0.99
Varicella-zoster virus immunizes patas monkeys against simian varicella-like disease. J Gen Virol (1979) 0.96
A possible role for glycoprotein gpV in the pathogenesis of varicella-zoster virus. Adv Exp Med Biol (1990) 0.95
Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus. Vaccine (2007) 0.95
Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child. Ann Emerg Med (2008) 0.95
Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts. J Virol Methods (2008) 0.95
Experimental simian varicella virus infection of St. Kitts vervet monkeys. J Med Primatol (1998) 0.94
Subclinical reactivation of varicella-zoster virus in immunocompromised and immunocompetent individuals. Intervirology (1998) 0.93
The genomes of simian varicella virus and varicella zoster virus are colinear. Virus Res (1992) 0.92
Recombinant simian varicella viruses induce immune responses to simian immunodeficiency virus (SIV) antigens in immunized vervet monkeys. Virology (2007) 0.91
Cloning the simian varicella virus genome in E. coli as an infectious bacterial artificial chromosome. Arch Virol (2011) 0.90
Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen. J Med Virol (2001) 0.88
Induction of immune responses to SIV antigens by mucosally administered vaccines. AIDS Res Hum Retroviruses (1999) 0.87
Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine. Vaccine (2007) 0.86
Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge. Vaccine (2004) 0.86
Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs. J Virol (1995) 0.85
Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic. J Gen Virol (2008) 0.85
Management of varicella infection (chickenpox) in pregnancy. J Obstet Gynaecol Can (2012) 0.85
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity. J Gen Virol (2005) 0.84
Processing of hepatitis B virus surface antigen expressed by recombinant Oka varicella vaccine virus. J Gen Virol (1992) 0.83
Novel immunogenicity of Oka varicella vaccine vector expressing hepatitis B surface antigen. J Infect Dis (2000) 0.83
Experience with use of Zostavax(®) in patients with hematologic malignancy and hematopoietic cell transplant recipients. Am J Hematol (2011) 0.83
Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines. Comp Immunol Microbiol Infect Dis (2007) 0.82
Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques. Vaccine (2010) 0.81
Rapid and efficient introduction of a foreign gene into bacterial artificial chromosome-cloned varicella vaccine by Tn7-mediated site-specific transposition. Virology (2010) 0.79
Antigen-specific T-cell induction by vaccination with a recombinant Sendai virus vector even in the presence of vector-specific neutralizing antibodies in rhesus macaques. Biochem Biophys Res Commun (2008) 0.77